The Biological Effects of C/EBPalpha in K562 Cells Depend on the Potency of the N-terminal Regulatory Region, Not on Specificity of the DNA Binding Domain

Overview

Journal J Biol Chem

Specialty Biochemistry

Date 2010 Jul 28

PMID 20659895

Citations 6

Authors

Giovanna Ferrari-Amorotti

Samanta Antonella Mariani

Chiara Novi

Sara Cattelani

Luisa Pecorari

Francesca Corradini

Angela Rachele Soliera

Gloria Manzotti

Valentina Fragliasso

Ying Zhang

Robert V Martinez

Eric W-F Lam

Clara Guerzoni

Bruno Calabretta

Affiliations

Soon will be listed here.

Abstract

The transcription factor C/EBPα is more potent than C/EBPβ in inducing granulocitic differentiation and inhibiting BCR/ABL-expressing cells. We took a "domain swapping" approach to assess biological effects, modulation of gene expression, and binding to C/EBPα-regulated promoters by wild-type and chimeric C/EBPα/C/EBPβ proteins. Wild-type and N-C/EBPα+ C/EBPβ-DBD induced transcription of the granulocyte-colony stimulating factor receptor (G-CSFR) gene, promoted differentiation, and suppressed proliferation of K562 cells vigorously; instead, wild-type C/EBPβ and N-C/EBPβ+C/EBPα-DBD had modest effects, although they bound the G-CSFR promoter like wild-type C/EBPα and N-C/EBPα+C/EBPβ-DBD. Chimeric proteins consisting of the TAD of VP16 and the DBD of C/EBPα or C/EBPβ inhibited proliferation and induced differentiation of K562 cells as effectively as wild-type C/EBPα. Gene expression profiles induced by C/EBPα resembled those modulated by N-C/EBPα+C/EBPβ-DBD, whereas C/EBPβ induced a pattern similar to that of N-C/EBPβ+C/EBPα-DBD. C/EBPα activation induced changes in the expression of more cell cycle- and apoptosis-related genes than the other proteins and enhanced Imatinib-induced apoptosis of K562 cells. Expression of FOXO3a, a novel C/EBPα-regulated gene, was required for apoptosis but not for differentiation induction or proliferation inhibition of K562 cells.

Citing Articles

Transcription factor binding site clusters identify target genes with similar tissue-wide expression and buffer against mutations.

Lu R, Rogan P F1000Res. 2019; 7:1933.

PMID: 31001412 PMC: 6464064. DOI: 10.12688/f1000research.17363.2.

The Philadelphia chromosome in leukemogenesis.

Kang Z, Liu Y, Xu L, Long Z, Huang D, Yang Y Chin J Cancer. 2016; 35:48.

PMID: 27233483 PMC: 4896164. DOI: 10.1186/s40880-016-0108-0.

[The expression and role of the transcription factor C/EBPα in chronic myeloid leukemia].

Zhang G, Dong F, Luan C, Zhang X, Shao H, Liu J Zhonghua Xue Ye Xue Za Zhi. 2015; 36(11):947-50.

PMID: 26632469 PMC: 7342430. DOI: 10.3760/cma.j.issn.0253-2727.2015.11.012.

Monocyte-macrophage differentiation of acute myeloid leukemia cell lines by small molecules identified through interrogation of the Connectivity Map database.

Manzotti G, Parenti S, Ferrari-Amorotti G, Soliera A, Cattelani S, Montanari M Cell Cycle. 2015; 14(16):2578-89.

PMID: 26102293 PMC: 4614550. DOI: 10.1080/15384101.2015.1033591.

Expression of p89(c-Mybex9b), an alternatively spliced form of c-Myb, is required for proliferation and survival of p210BCR/ABL-expressing cells.

Manzotti G, Mariani S, Corradini F, Bussolari R, Cesi V, Vergalli J Blood Cancer J. 2012; 2(5):e71.

PMID: 22829973 PMC: 3366069. DOI: 10.1038/bcj.2012.16.

References

Scott L, Civin C, Rorth P, Friedman A . A novel temporal expression pattern of three C/EBP family members in differentiating myelomonocytic cells. Blood. 1992; 80(7):1725-35. View

Preston C, Frame M, CAMPBELL M . A complex formed between cell components and an HSV structural polypeptide binds to a viral immediate early gene regulatory DNA sequence. Cell. 1988; 52(3):425-34. DOI: 10.1016/s0092-8674(88)80035-7. View

Muller C, Calkhoven C, Sha X, Leutz A . The CCAAT enhancer-binding protein alpha (C/EBPalpha) requires a SWI/SNF complex for proliferation arrest. J Biol Chem. 2003; 279(8):7353-8. DOI: 10.1074/jbc.M312709200. View

Wang H, Iakova P, Wilde M, Welm A, Goode T, Roesler W . C/EBPalpha arrests cell proliferation through direct inhibition of Cdk2 and Cdk4. Mol Cell. 2001; 8(4):817-28. DOI: 10.1016/s1097-2765(01)00366-5. View

Perrotti D, Cesi V, Trotta R, Guerzoni C, Santilli G, Campbell K . BCR-ABL suppresses C/EBPalpha expression through inhibitory action of hnRNP E2. Nat Genet. 2001; 30(1):48-58. DOI: 10.1038/ng791. View

Pabst T, Mueller B, Zhang P, Radomska H, Narravula S, Schnittger S . Dominant-negative mutations of CEBPA, encoding CCAAT/enhancer binding protein-alpha (C/EBPalpha), in acute myeloid leukemia. Nat Genet. 2001; 27(3):263-70. DOI: 10.1038/85820. View

Fernandez de Mattos S, Essafi A, Soeiro I, Pietersen A, Birkenkamp K, Edwards C . FoxO3a and BCR-ABL regulate cyclin D2 transcription through a STAT5/BCL6-dependent mechanism. Mol Cell Biol. 2004; 24(22):10058-71. PMC: 525464. DOI: 10.1128/MCB.24.22.10058-10071.2004. View

Tavor S, Park D, Gery S, Vuong P, Gombart A, Koeffler H . Restoration of C/EBPalpha expression in a BCR-ABL+ cell line induces terminal granulocytic differentiation. J Biol Chem. 2003; 278(52):52651-9. DOI: 10.1074/jbc.M307077200. View

Mcknight J, Kristie T, Roizman B . Binding of the virion protein mediating alpha gene induction in herpes simplex virus 1-infected cells to its cis site requires cellular proteins. Proc Natl Acad Sci U S A. 1987; 84(20):7061-5. PMC: 299229. DOI: 10.1073/pnas.84.20.7061. View

10.

Ghaffari S, Jagani Z, Kitidis C, Lodish H, Khosravi-Far R . Cytokines and BCR-ABL mediate suppression of TRAIL-induced apoptosis through inhibition of forkhead FOXO3a transcription factor. Proc Natl Acad Sci U S A. 2003; 100(11):6523-8. PMC: 164479. DOI: 10.1073/pnas.0731871100. View

11.

Bereshchenko O, Mancini E, Moore S, Bilbao D, Mansson R, Luc S . Hematopoietic stem cell expansion precedes the generation of committed myeloid leukemia-initiating cells in C/EBPalpha mutant AML. Cancer Cell. 2009; 16(5):390-400. DOI: 10.1016/j.ccr.2009.09.036. View

12.

Kirstetter P, Schuster M, Bereshchenko O, Moore S, Dvinge H, Kurz E . Modeling of C/EBPalpha mutant acute myeloid leukemia reveals a common expression signature of committed myeloid leukemia-initiating cells. Cancer Cell. 2008; 13(4):299-310. DOI: 10.1016/j.ccr.2008.02.008. View

13.

Ramji D, Foka P . CCAAT/enhancer-binding proteins: structure, function and regulation. Biochem J. 2002; 365(Pt 3):561-75. PMC: 1222736. DOI: 10.1042/BJ20020508. View

14.

DAlo F, Johansen L, Nelson E, Radomska H, Evans E, Zhang P . The amino terminal and E2F interaction domains are critical for C/EBP alpha-mediated induction of granulopoietic development of hematopoietic cells. Blood. 2003; 102(9):3163-71. DOI: 10.1182/blood-2003-02-0479. View

15.

Screpanti I, Romani L, Musiani P, Modesti A, Fattori E, Lazzaro D . Lymphoproliferative disorder and imbalanced T-helper response in C/EBP beta-deficient mice. EMBO J. 1995; 14(9):1932-41. PMC: 398292. DOI: 10.1002/j.1460-2075.1995.tb07185.x. View

16.

Guerzoni C, Bardini M, Mariani S, Ferrari-Amorotti G, Neviani P, Panno M . Inducible activation of CEBPB, a gene negatively regulated by BCR/ABL, inhibits proliferation and promotes differentiation of BCR/ABL-expressing cells. Blood. 2006; 107(10):4080-9. PMC: 1895282. DOI: 10.1182/blood-2005-08-3181. View

17.

Duprez E, Wagner K, Koch H, Tenen D . C/EBPbeta: a major PML-RARA-responsive gene in retinoic acid-induced differentiation of APL cells. EMBO J. 2003; 22(21):5806-16. PMC: 275413. DOI: 10.1093/emboj/cdg556. View

18.

Tenen D . Disruption of differentiation in human cancer: AML shows the way. Nat Rev Cancer. 2003; 3(2):89-101. DOI: 10.1038/nrc989. View

19.

Sadowski I, Ma J, Triezenberg S, Ptashne M . GAL4-VP16 is an unusually potent transcriptional activator. Nature. 1988; 335(6190):563-4. DOI: 10.1038/335563a0. View

20.

Porse B, Pedersen TA , Xu X, Lindberg B, Wewer U, Friis-Hansen L . E2F repression by C/EBPalpha is required for adipogenesis and granulopoiesis in vivo. Cell. 2001; 107(2):247-58. DOI: 10.1016/s0092-8674(01)00516-5. View